Skoči na glavni sadržaj

Colchicine as an oral corticosteroid sparing agent for asthma

Asthma can be treated with drugs which aim to reduce inflammation in the airways. Inhaled corticosteroids are frequently used, but occasionally individuals require oral steroids for adequate control. However, oral steroids are frequently associated with severe side-effects. Colchicine has been suggested as a useful 'add-on' therapy to oral steroid treatment with the aim of reducing the dose requirement in such asthma. There is a need for well-designed trials addressing this question before recommendations can be made.

Uvod

Oral corticosteroids are used as a treatment for asthma, but they are often associated with serious side effects. Colchicine is an anti-inflammatory, immuno modulating agent, which could potentially have a beneficial effect in the treatment of asthma as well as act as a steroid-sparing agent.

Ciljevi

To determine the effectiveness of colchicine as an oral corticosteroid sparing agent for in the treatment of chronic asthma.

Metode pretraživanja

We searched the Cochrane Airways Group Specialised Register (to November 2009), SIGLE (1980 to 2001) and reference lists of potential articles. We also contacted researchers in the field.

Kriteriji odabira

Randomised controlled trials investigating the addition of colchicine compared to placebo in stable steroid dependent asthmatics.

Prikupljanje podataka i obrada

No trials were found that met the inclusion criteria.

Glavni rezultati

We were unable to perform any meta-analyses. Two small studies have assessed the efficacy of colchicine subsequent to inhaled steroid withdrawal and as a tapering agent in inhaled steroids. Both studies failed to detect a significant difference between colchicine and placebo. An update search conducted in November 2009 did not identify any new trials.

Zaključak autora

No relevant trials have been published, so there is no evidence to indicate that colchicine is beneficial or otherwise in the management of steroid-dependent asthmatic patients. There is a need for well designed randomised controlled trials to be performed.

Citat
Dewey A, Bara A, Lasserson TJ, Walters EH. Colchicine as an oral corticosteroid sparing agent for asthma. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD003273. DOI: 10.1002/14651858.CD003273.

Naše korištenje kolačića

Koristimo nužne kolačiće kako bi naša web stranica radila. Željeli bismo postaviti i neobavezne analitičke kolačiće koji će nam pomoći da ju poboljšamo. Nećemo postaviti neobavezne kolačiće ako ih ne omogućite. Korištenjem ovog alata postavit će se kolačić na vaš uređaj, kako bi zapamtili vaše postavke. Svoje postavke kolačića možete promijeniti u bilo kojem trenutku klikom na vezu "Postavke kolačića" u podnožju svake stranice.
Za detaljnije informacije o kolačićima koje koristimo pogledajte našu stranicu Kolačići.

Prihvati sve
Postaviti